Transenterix Inc
NYSEARCA:TRXC (3/4/2021, 7:04:00 PM)
After market: 3.79 -0.29 (-7.11%)4.08
-0.46 (-10.13%)
TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.
Transenterix Inc
635 DAVIS DRIVE SUITE 300
MORRISVILLE NC 27560
P: 919-765-8400
CEO: Anthony Fernando
If you're interested in Asensus and TRXC stock, be prepared to invest time and money. It will take 5 years to know if you have a winner here.
Hot Penny Stocks To Add To Your Watch List This Week
Shares of TRXC stock are rising on Wednesday after the firm received general surgery clearance from the FDA for its Senhance Surgical System.
Here you can normally see the latest stock twits on TRXC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: